Skip to main content
. 2018 Jun 22;16:36–38. doi: 10.1016/j.ymgmr.2018.05.004

Table 1.

Newborn screening data for propionic acidemia cases in Wisconsin Amish.

Case Sex Time of collection Acylcarnitine profile
Second tier testing
Diagnosis confirmation
C3a
C3/C2
MMA
MCA
nml < 5.00 μM (Cases 1 through 4)
nml < 6.92 μM (Cases 5 through 8)
nml < 0.20 nml < 3.00 μM nml < 1.00 μM
PA cases: Identified by newborn screening
1 F 41 h 9.05 0.29 0.21 2.12 Homozygous c.1606A>G
2 M 48 h 10.08 0.44 0.16 3.39 Homozygous c.1606A>G
3 F 36 h 5.47 0.27 0.28 3.26 Homozygous c.1606A>G
4 M 31 h 15.05 0.41 0.14 2.98 Homozygous c.1606A>G
5 M 24 h 7.27 0.35 NA NA Homozygous c.1606A>G
6 F 96 h 7.68 0.26 NA NA Abnormal urine organic acids (presence of methylcitric acid)
7b F 96 h 4.28 0.16 NA NA Abnormal urine organic acids (presence of methylcitric acid)
5.92 0.21



PA case: Missed by newborn screening
8 F 38 h 3.11 0.13 NA NA Normal urine organic acids; Homozygous c.1606A>G
a

From 2000 to 2010, normal C3 value was <6.92 μM (cases 5 through 8). From 2011 to current, normal C3 value is <5.00 μM (cases 1 through 4).

b

Specimen evaluated in duplicate due to a family history of Propionic acidemia.